Thomas Boyer
- Hepatology top 0.1%
- Liver Disease and Transplantation 56
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 46
- Nephrology top 0.5%
- Renal function and acid-base balance 8
- Pharmacology top 0.2%
- Drug-Induced Hepatotoxicity and Protection 8
- Surgery top 1%
- Organ Transplantation Techniques and Outcomes 24
-
- Glutathione Transferases and Polymorphisms 30
- Genomics, phytochemicals, and oxidative stress 28
-
- Acute Myeloid Leukemia Research 16
- Co-authors
- Ziv J. HaskalRichard WhalenTelfer B. ReynoldsGuadalupe García–TsaoPriscilla ZiaDonald A. VesseyArun J. SanyalRobert Strauss
- Cited by
- HepatologyEpidemiologyNephrology
- Partner nations
- United StatesFranceCanada
In The Last Decade
Thomas Boyer
148 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Hepatology 4.8k
- Epidemiology 3.9k
- Nephrology 687
- Pharmacology 811
- Surgery 2.6k
Countries citing papers authored by Thomas Boyer
This map shows the geographic impact of Thomas Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Boyer more than expected).
Fields of papers citing papers by Thomas Boyer
This network shows the impact of papers produced by Thomas Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Boyer. The network helps show where Thomas Boyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Boyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2020 | 8 | |
| 3 | 2020 | 3 | |
| 4 | 2019 | 29 | |
| 5 | 2017 | 3 | |
| 6 | 2015 | 15 | |
| 7 | Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascitesbreakdown → | 2015 | 559 |
| 8 | 2014 | 42 | |
| 9 | 2009 | 405 | |
| 10 | 2008 | 25 | |
| 11 | Terlipressin for the treatment of hepatorenal syndrome | 2007 | 1 |
| 12 | 2007 | 50 | |
| 13 | 2005 | 124 | |
| 14 | 2005 | 309 | |
| 15 | 2003 | 105 | |
| 16 | 2000 | 162 | |
| 17 | 1998 | 7 | |
| 18 | 1993 | 2 | |
| 19 | 1991 | 30 | |
| 20 | Double blind controlled trial of corticosteroid therapy in severe alcoholic hepatitis with encephalopathy | 1978 | 5 |
About Thomas Boyer
Thomas Boyer is a scholar working on Hepatology, Hematology and Pharmacology, having authored 157 papers that have together received 7.5k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (56 papers), Liver Disease Diagnosis and Treatment (46 papers), Glutathione Transferases and Polymorphisms (30 papers), Genomics, phytochemicals, and oxidative stress (28 papers), Organ Transplantation Techniques and Outcomes (24 papers), Acute Myeloid Leukemia Research (16 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Renal function and acid-base balance (8 papers). The work is most often cited by research in Hepatology (4.8k citations), Epidemiology (3.9k citations) and Nephrology (687 citations). Thomas Boyer has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Ziv J. Haskal, Richard Whalen, Telfer B. Reynolds, Guadalupe García–Tsao, Priscilla Zia, Donald A. Vessey, Arun J. Sanyal, Robert Strauss, D. R. Triger and Florence Wong. Their work appears in journals such as Hepatology, Gastroenterology, Biochemical Journal, Journal of Hepatology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.